We exist to improve the lives
of everyone affected by epilepsy

New study into magnesium valproate as effective therapy

13 November, 2000

A study of 320 people with epilepsy by the Regional Epilepsy Centre in Milan has shown that magnesium valproate is effective as monotherapy in patients with newly diagnosed or previously treated partial or generalised epilepsy.

The study, reported in the October edition of 'Clinical Drug Investigation' journal, showed that 95 per cent of those who received magnesium valproate saw a reduction in the frequency of their seizures by over 50 per cent. For certain types of seizure, such as clonic, tonic, atonic or secondarily generalised seizures, the group saw a complete remission of seizures.

The report states that only 1 in 20 of the adverse effects of the treatment were considered to be serious.